PASNO - Pakistan Society of Neuro-Oncology

03/06/2026

Do you have an innovative workshop that can impact the world of Neuro-Oncology? We want to hear from you!

For the 7th Annual Neuro-Oncology Symposium, we are welcoming multidisciplinary proposals from global and local faculty to be part of our October program at JPMC.

✅ Focus Areas: AI, Neurosurgery, Neuroimaging, Research, and more.
✅ Format: We prioritize innovative and interactive sessions.

📍 Location: JPMC, Karachi
🗓️ Submission Deadline: 30th June, 2026

🔗 Apply now via the link below:
https://docs.google.com/forms/d/e/1FAIpQLScq4pHiC4W6QB1qY52jqK9xBNrguQ6J_wEcmdVA8TptSHqWWA/viewform?usp=header

Syed Ather Enam Aga Khan University PASNO - Pakistan Society of Neuro-Oncology

02/06/2026

CALL FOR ABSTRACTS – 7ANOS 2026

Join the 7th Annual Neuro-Oncology Symposium (7ANOS) and be part of an international platform dedicated to advancing neuro-oncology research.

Event Dates: 2nd – 4th October 2026
Abstract Submission Deadline: 30 June 2026

We invite researchers, clinicians, and students to submit abstracts and contribute to cutting-edge neuro-oncology discussions.

Submit abstract: www.pasno.org
Queries: [email protected]

Selected abstracts may be considered for publication in the Journal of the Pakistan Medical Association (JPMA).

Don’t miss this opportunity to present your research internationally!

Syed Ather Enam PASNO - Pakistan Society of Neuro-Oncology

27/05/2026

May our shared commitment to purpose and substance continue to guide our path forward. Eid Mubarak!

07/05/2026

7ANOS 2026: Challenges. Innovations. Impact.

The most significant date in the Neuro-Oncology calendar is set. We are gathering to redefine excellence in the "Real World" of Neuro-Oncological care.

The journey from challenge to innovation starts here!

📍 Mark Your Calendars: 2nd – 4th October 2026
Don't miss the 7th Annual Neuro-Oncology Symposium.

Syed Ather Enam PASNO - Pakistan Society of Neuro-Oncology Aga Khan University

15/04/2026

From Pledge to Progress: Representing Pakistan in Dar es Salaam.

One year ago, at the Boston Declaration on Global Neurosurgery, Dr. Syed Ather Enam pledged to revolutionize neurosurgical training in Pakistan.

Today, we are proud to share that he is presenting the Year 1 Progress Report at the one-year assessment session in Tanzania.

Through the dedicated efforts of the Pakistan Academy of Neurological Surgery (PANS) and the PASNO - Pakistan Society of Neuro-Oncology (PASNO), we have seen:

✅ A 25% growth in hands-on SPIN workshop participation.
✅ Successful foundational Bootcamps for junior residents.
✅ Multidisciplinary impact through ANOS.
✅ Successful PNOTB series.

We are not just training surgeons; we are building a sustainable ecosystem for the future of neurosurgery.

17/03/2026

Big Opportunity for Neuro-Oncology Professionals!

PASNO is proud to partner in the 6th Annual Update in Neuro-Oncology, in collaboration with Harvard Medical School Continuing Education.

🌍 Special Opportunities for LMICs:
✨ Unlock world-class learning with:
🔹 50% discounted registration for professionals and trainees from LMICs
🔹 One full-tuition scholarship for a PASNO nominee

🎟 Discount Code: LMIC50OFF

📅 Course Dates: July 22–24, 2026
💻 Format: Live Virtual CME Course
🎥 Access: Session recordings available for 60 days
⏳ Nomination Deadline: June 1, 2026

Don’t miss this opportunity to learn from global experts and advance neuro-oncology care!

Harvard University Pakistan Academy of Neurological Surgery

05/03/2026

📢 Call for Applications – ASNO–SNO Clinical Trials Scholars Course (CDW)

Early-career faculty, fellows, trainees, and clinician-scientists are invited to apply for the ASNO–SNO Clinical Trials Scholars Course – Concept Development Workshop, taking place 11 June 2026 in Kanazawa, Japan.

Participants will receive mentorship from international leaders in neuro-oncology, and the Top 4 applicants will receive a USD 500 educational grant to support travel and accommodation.

⏰ Application Deadline: 6 March 2026
🔗 Apply here: https://site2.convention.co.jp/asno2026/clinical/

21/02/2026